PERSPECTA

News from every angle

← Back to headlines

Canada’s GLP-1 Medication Sales on Track to Set Annual Record in 2026

Market data reveals that Canadian consumers spent $2.4 billion on GLP-1 drugs in the first half of 2026, reflecting sustained high demand for weight-management and diabetes treatments.

27 Aug, 19:27 — 27 Aug, 19:27
PostShare

Sources

Showing 1 of 1 sources
globe-and-mailHigh1d ago

GLP-1 sales in Canada on pace to set a new record this year

In the first half of 2026, $2.4-billion worth of GLP-1 drugs were sold in Canada

By Chris Hannay

Read full article →

Related Stories

Two German Airport Workers Die of Malaria Contracted on Flight

2h ago

Dolly Parton’s Sister Reveals Details of Singer’s Final Days

4h ago

Garbage Dump Collapse Traps Building in Nigeria, Killing Two Residents

6h ago

BioNTech Ends Mid-Stage Colorectal Cancer Vaccine Trial

6h ago